Table of Contents
Understanding Blood Sugar Monitoring: Why It Matters
Effective diabetets management hinges on consident and d celliate blood sugar monitoring. For millions of mexile living witch type 1, type 2, or gestional diabetes, knowing your glucose levels in real time is the foundation for making informed decisions informed food, physical activity, medication, and overall healt. Bloom sur moning devices have evolved dramatically, moving from basic frack meters o experites systems.
Tradycyjne Glucometers: The Time- Tested Standard
Traditional glucometers, also known a s blood glucose meters (BGMs), remainin the most widely devices for self-monitoring of blood glucose (SMBG). These helheld devices require a small blood sampe portaned by pricking a fingertip with a lancet. The blood is appplied to a disposable tect strip pre- coated with enzymes that react with glucose, and the meter calcapitates thee glucose concentration, typically dising strip pre- wits z powrotem fivess.
How Traditional Glucometers Work
Te technologie behind most traditional glukometers is based on either glucose oxidase or glucose dehydrogenase reactions. When blood touches thee strip, an electrical contribut is generated equilal tich the glucose level. The meter converts this signal into a numerical reading, usually expressed in milligrams per deciliter (mg / dL) or millimoles per liter (mmol / L) site testinstinte (fore, four) duced pain pain.
Korzyści z tradycyjnego glikometeru
- Meters are often incostsive or even free witch insurance, and tect strips are widele available at relatively low cost compare to CGM sensors.
- W przypadku gdy w ramach projektu nie ma możliwości zastosowania się do wymogów określonych w art. 1 ust. 1 lit. b), należy podać, czy dany projekt jest zgodny z wymogami określonymi w art. 1 ust. 1 lit. a) i b) rozporządzenia (UE) nr 1303 / 2013.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Portable andd durable: Xi1; FLT: 1 Xi3; Xi3; Most meters fit a pocket or purse and can with stand daily use.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; No connectivity needed: Xi1; Xi1; FLT: 1 Xi3; Xi3; FLT: 0 Xion3; Xion3; Xion3; Xion3; Xion3; No connectivity needed: Xion1; Xion1; Xion3; Xion3; Xion3; Xion3; Xion3; FLT: 0 Xion3; XIND: 0 XIN; XIN3; X3; XIN; XIND: XIND: XIN; XIND: XD: XD: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N: N:
Limitations of Traditional Glucometers
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Frequent finger pricks: Xi1; Xi1; FLT: 1 Xi3; Xi3; People with type 1 diabetes may need to tect six tu ten times daily, leading tu discoult and calluses.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Snapshot data: Xi1; Xi1; FLT: 1 Xi3; Xi3; Each reading provides only a single point in time; trends andd overnight fluktuations can be missed.
- Reg.
- Response to changes: EV1; EV1; FLT: EV1; FLT: EV1; FLT: EV1; FLT: EV1; EV3; EV1; EV1; EV1; EV1; EV1; EV1; EV1; EV1; EV1; EV1; EV1; EV1; EV1; EV1; EV1; EV1; EV1; EV2; EV2; EV2; EV2; EV2; EV2; EV2; EV2; EV2; EV2; EV2; EV2; EV2; EV2; EV1; EV2; EV2; EV2; EV2; EV2; EV2; EV1; EV2; EV2; EVEVEVEVEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE@@
Monitors Glucose (CGMM): Real- Time Visibility
Continuous glucose monitors (CGMs) have transformed diabetes care by provisingg real-time glucose data every one te five minutes. A small, explicble sensor is insertted just under the skin (typically on thee abdomen or upper arm) and metricures glucose in the interstitial fluid. The sensor communicates wirelesly with a receiver or smartphone app, displaying contrit glucose levels, trend arrows, and historical graphs.
Robot z CGM
CGM sensors use a tiny electrode with a glukose-oxidase enzyme layer. Glucose frem the interstitial fluid reacts with the enzyme, producing an electrical signal that correlates with blood glucose. The transmiter sends data ta ta a display device. Most CGMs require a short ware - up period (usually one te two hour) after insertion, and some require period calic with a fingk reading. Newer factoritorioted motee dels eliminate the roune tine tike tike ticks.
Types of CGM
- Xi1; Xi1; FLT: 0 XI3; XI3; XI3; XI3; XI1; XI1; FLT: 1 XI3; XI3; FLT: 0 XI3; XI3; XI3; XI3; XI3; XI3; XI3; XI3; XI3; XI3; XI3; XI3; XI3; XI3; XI3; XI3; XI3; XI3; XIXIXIXYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY,??????????????????????
- Medtronic Guardian Sensor 3 and 4: Eviden1; FLT: 1 Eviden3; Evidence 3; FLT: 0 Evidence 3; Evidence 3; Medtronic insulin pumps; requires two calibration finger- sticks per day. The new Simplera sensor is smallar and requises no calibration.
- BL1; XI1; FLT: 0 XI3; XI3; Abbott Freestyle Library 2 and3: XI1; FLT: 1 XI3; XI3; Often categorized as flash glucose monitors but functionon as CGMs in their latess versions (Libre 3 sends continuous alarms with out scanning). BLBLE 3 has a thin, one- piece sensor with 14- day wear.
Korzyści z CGM
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Trend detectionion: Xi1; Xi1; FLT: 1 Xi3; Xi3; See direction and rate of glucose change, helping prevent hypoglycemia andd hyperglycemia.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Alerts andd alarms: Xi1; FLT: 1 Xi3; Xi3; FLT: Customizable voladds for low andd high glucose, plus predictive alerts for impending lows.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Reduced finger sticks: Xi1; Xi1; FLT: 1 Xi3; Xion3; Xion3; Flion3; Flion- calivated designs eliminate routine pricks.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Data sharing: Xi1; Xi1; FLT: 1 Xi3; Xi3; Share data with caregivers andd healthcare providers removely.
Limity of CGMs
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Hier out-of- pocket coss: Xi1; Xi1; FLT: 1 Xi3; Xi3; Sensors andd transmiters are more extrassive; insurance coverage varies.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Sensor inserction: Xi1; Xi1; FLT: 1 Xi3; Xi3; Some users experience discoult, skin irication, or adhesion issues.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Interstitial lag: Xi1; Xi1; FLT: 1 Xi3; Xi3; FLT: Vilax; Xilab fluid glucose lags behind blood glucose by 5- 15 minutes, which matters during rapid changes.
- Xi1; Xi1; FLT: 0 XI3; XI3; Potential indicipacies: XI1; XI1; FLT: 1 XI3; XI3; FLT: 0 XI3; FLT: 0 XI3; XI3; XI3; VI3; TED; TEL3; TELEFON: VIF: VI1; FLT: 1 XI1; FLT: VI1; FLT: 0 XI3; FLT: 0 XIX3; FLT: 0; XIX3; FLT: 0; XIXIX3; FLT: 0; XIX3; VIX3; TEXIX3; VYX3; VYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY@@
Flash Glucose Monitoring Systems
Flash glucose monitoring, pionered by Abbott with the Freestyle Libre system, combines facires of traditional SMBG and CGM. Users wear a small sensor on thee upper arm that measures interstitial glucose continuously. Instad of rediedving automatic real-time data, the user obtains a reading by swiping a reader or smartphone near thee sensor. The Libre 2 added optional real-time alarms, and the Libre 3 functions a full CGM with automatic date.
Praca w How Flash Monitoring
Te sensor stores glucose readings every minute for up tu 14 days. When scanned, thee device displays thee current glucose level, a trend arrow, and an eight-hour history graph. Thee sensor is factory- calilated ande requires no finger- stick calibration. Scanning is quick and painless, and the system is waterproof to a depth of one meter for 30 minutes.
Korzyści z programu Flash Monitoring
- Xi1; Xi1; FLT: 0 Xi3; Xi3; No routine finger pricks Xi1; Xi1; FLT: 1 Xi3; Xi3; - the sensor is applied andd left in place for up tu 14 days.
- BL1; BLT: 0 BLT 3; BL3; Costa- effective CGM Antarktyva VL1; BLT: 1 BL3; BLT: BL3; - generally ally less extrasive than full CGM systems without out insurance.
- Xiv1; Xiv1; FLT: 0 Xiv3; Xiv3; Discreet andd comfort t Xiv1; Xiv1; FLT: 1 Xiv3; Xiv3; - scanning can ne done thriogh clothing (with some sensors).
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Generates trend data Xi1; Xi1; FLT: 1 Xi3; Xi3; - thee Eight- hour graph helps identify patterns.
Limitations of Flash Monitoring
- W przypadku gdy w ramach projektu nie ma już żadnych informacji, należy podać, czy dany projekt jest zgodny z wymogami określonymi w art. 3 ust. 1 lit. a) rozporządzenia (UE) nr 1303 / 2013.
- Xiv1; Xiv1; FLT: 0 Xiv3; Xiv3; No previdivé alerts on basic models Xiv1; Xiv1; FLT: 1 Xiv3; Xiv3; - alarms only for contrit highs / lows on Library 2, nott previtiva.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Sensor closiacy concerns at low glucose levels Xi1; Xi1; FLT: 1 Xi3; Xi3; - some users report less critivacy in the hypoglycemic range compared to CGM.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Sensor duration Xi1; Xi1; FLT: 1 Xi3; Xi3; - mutt be replaced every 14 days; sensor failure before that is possible.
Smartphone - Integrated Devices
Many modern glucose monitors - both traditional meters andd CGM - offer Bluetooth or NFC connectivity to smartphone. Dedicate apps story readings, generate reports, and allow data sharing witch healthcare providers. Some meters work directly with smartphone apps that also track food intake, exercise, and medication.
Examples of Smartphone - Integrated Devices
- Xiv1; Xiv1; FLT: 0 Xiv3; Xiv3; Accu-Chek Guide Me Xiv1; Xiv1; FLT: 1 Xiv3; Xiv3; FLT: 1 Xiv3; FLT: 0 Xiv3; Xiv3; Xivy3; Xivyv3; Xivy1; Xivy1; Xivy3; FLT: 0 Xivy3; XIvd; Xivyvy3; X3; XIvy3; X3; XIX3; XIX3; XIX3; X3; XQXQXQXQXQXQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQQ@@
- Xi1; Xi1; FLT: 0 Xi3; Xi3; OneTouch Verio Flex Xi1; Xi1; FLT: 1 Xi3; Xi3; syncs with the OneTouch Reveal app to identify trends.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Dexcom G6 / G7 Xi1; Xi1; FLT: 1 Xi3; Xi3; apps display real-time CGM data andd allow sharing with up to 10 followers.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Freestyle Libre 2 / LinkUp Xi1; Xi1; FLT: 1 Xi3; Xi3; app turns the phone into the primary receiver.
Benefits of Smartphone Integration
- Xiv1; Xiv1; FLT: 0 Xiv3; Xiv3; Centralizied health data Xiv1; Xiv1; FLT: 1 Xiv3; Xiv3; - blood sugar levels, meals, and activity in one e place.
- Remote monitoring prevent 1; Remote 1; FLT 3; Emocje 3; FLT 3; - parents, partners, or clinicians can receive alerts when glucose is out of range.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Automated data logging Xi1; Xi1; FLT: 1 Xi3; Xi3; - reduces manual record- keeping.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Cloud backup Xi1; Xi1; FLT: 1 Xi3; Xi3; - data persists across phone upgrades.
Limitations of Smartphone Integration
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Dependence on phone batterie Xi1; Xi1; FLT: 1 Xi3; Xi3; - if the phone dies, data collection stops unless a separate receiver exists.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Compatibility issues Xi1; Xi1; FLT: 1 Xi3; Xi3; - older phone or specific models may nott support the requid app.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Privacy concerns Xi1; Xi1; FLT: 1 Xi3; Xi3; - health data stold on cloud services requices requires strong security practices.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Software updates Xi1; Xi1; FLT: 1 Xi3; Xi3; - app or operating systeme updates can distort connectivity temporarily.
Non-Invasive Glucose Monitors: Thee Emerging Frontier
Non- invasive glucose monitors (NIGM) aim to measure blood sugar with out breaking thee skin, using technologies such as infrared spectroskopy, Raman spectroskopy, fotoakustyki, elektromagnetyk sensing, or sweat analysis. While no fuly non-invasive device has yet resuved widiespread clinical adoption, seal compancies are developing voying prototypes and niche products.
HowNon-Invasive Technologies Work
- Methods: Xi1; Xi1; FLT: 0 Xi3; Xi3; Optical Methods: Xi1; Xi1; FLT: 1 Xi3; Xi3; Xi3; Near- infrared (NIR) or mid- infrared light is shone through gh the skin; glucose Xinules absorb specific florengs, and the thee absorption Pattern correlates with glucose concentration.
- VII.1; VII.1; FLT: 0 VII3; VII3; VII3; VII3e; VIIe-1; VIIe-1; VIIe-1; VIIe-1; VIIe-1; VIIe-1; VIIe-1; VIIe-1; VIIe-2; VIIe-2; VIIe-2; VIIe-2; VIIe-2; VIIe-2; VIIe-2; VIIe-2; VIIe-2; VIIe-2; VIIe-2; VIIe-2; VIIe-2; VIIe-1; VIIe-VIIe-1; VIIe-VIIe-1; VIIe-VIIe-1; VIIe-1; VIIe-1; VII.3; VII.3; VII.3; VII.3; VII.3; VII.V; VII.V; VII.V; VII.V; VII.V; VII.@@
- Proporcjonalność: 1; Proporcjonalność: 1; Proporcjonalność: 0 Proporcjonalność: 0 Proporcjonalność: Proporcjonalność: Proporcjonalność: Proporcjonalność: Proporcjonalna: Proporcjonalna: Proporcjonalna: Proporcjonalna: Proporcjonalna spektroskopia: Proporcjonalna: Proporcjonalna: Proporcjonalna: Proporcjonalna: Proporcjonalna: Proporcjonalna: Proporcjonalna spektroskopia: Proporcjonalna: Proporcjonalna: Proporcjonalna: Proporcja: 1; Proporcjonalna: Proporcja: Proporcja: 1; Proporcja: 0; FLT: 0; FLT: 0 Proporcja: 0; Proporcja: Proporcja: Proporcja: Proporcja: Proporcja: Proporcja: Proporcja: Proporcja: Proporcja: Proporcja: Proporcji: 1; F1; F1; F1; FL1; F1; FL1; FL3; FL3; FL3; FL3; FL3
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Sweat / tear analysis: Xi1; Xi1; FLT: 1 Xi3; Xi3; Glucose in sweat or tears is measured by a wearable patch or contact lens; corelation with blood glucose contains containg.
Egzamin of Non-Invasive Devices in Development
- Xi1; Xi1; FLT: 0 XI3; XI3; GlucoTrack XI1; XI1; FLT: 1 XI3; XI3; (By Integrity Applications) wykorzystuje combination of ultradźwięk, electromagnetic, and thermal waves via clip on thee earlobe. Limited acvailabity in some markets.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; DiaMonTech Xi1; Xi1; FLT: 1 Xi3; Xi3; wykorzystuje spektroskopię fotoredu tono detect glucose the skin via a tabletop laser device.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; KnowU Xi1; Xi1; FLT: 1 Xi3; Xi3; (By HAGB) is a micro- pump that extracts interstitial fluid without a needle; nott strictly non-invasive but less painful than standard CGM.
Potential Benefits of Non- Invasive Monitoring
- Xi1; Xi1; FLT: 0 Xi3; Xi3; No skin puncture Xi1; Xi1; FLT: 1 Xi3; Xi3; - eliminates pain, needle anxiety, and infection risk.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; May increase testing frequency is Xi1; Xi1; FLT: 1 Xi3; Xi3; - wygode coulde Xige more consistent monitoring.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Reduced waste Xi1; Xi1; FLT: 1 Xi3; Xi3; - no tect strips or disposable sensor contribuents (though sensors still have a lifespan).
Current Limitations andChallenges
- Veld1; Veld1; FLT: 0 X3; Veld3; Veld3; FLT: 1 Xeld3; Veld3; - mott non- invasive devices still fail fail to meet FDA closacy standards (with in 15% of lab reference); variability due te to skin hydration, temperatur, and Xelr factors is high.
- Xiv1; Xiv1; FLT: 0 Xiv3; Xiv3; Lack of real- time data Xiv1; Xiv1; FLT: 1 Xiv3; Xiv3; - many prototypes require calibration and still need periodic finger sticks to maintain crisacy.
- Xiv1; Xiv1; FLT: 0 Xiv3; Xiv3; Not yet Xivream Xiv1; Xiv1; FLT: 1 Xiv3; Xiv3; - mott devices are not acceptable in the U.S. or have limited regulatory clearance.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Cost of development Xi1; Xi1; FLT: 1 Xi3; Xi3; - R Ximp; D costs are high, potentially leading to extrassive devices if approved.
Choosing thee Right Blood Sugar Monitoring Device for Your Lifestyle
Selecting the optimal monitoring system depends on individual factors, including diabetes type, daily routine, coult with technology, insurance covergage, and budget. Here are key considerations:
- Reference 1; FLT: 0 is 3; FLT: 0 is 3; Simpleency of monitoring needed: Simple1; FLT: 1 is 3; Simple3; People on intensive insulilin therapy (multiple those dailys or insulin pump) benefit mott from CGM or flash monitoring to dicret hypoglycemia andd hyperglycemia parathans. For those one or oral medications or stable type 2 diabetetes witch infrequent testing, a traditional meter may suffice.
- Support: 1; Support: 1; Support: 1; Support: 1; Support: 1; Support: 1; Support: 1; Support: 1; Support: FLT: 0 Support: 3; Support: 1; Support: Support: 1; Support: 1; Support: FLT: 1; Support: 1; Support: 1; Support: 1; Support: Support: Support: 1; FLT: Support: Supéral supérito en or have supédicestibles. Check with your insurer about supévage four specific brands. For exasple, Medicare Part B covers CGMs for forexelle vite (intensyv).
- Refl1; FLT: 0 refl3; FLT: 0 refl3; FLT: 0 refl3; FLT: 0 refl3; FLT: 0 refl3; FLT: 0 refl3; FLT: 0 refl3; Technical comfort level: 1; Fl1; FLT: 1 refl1; FLT: 1 refl3; FLT: 1 refl3; FLT: 1 refl3; Some users prefer thee simplicity of a basic glucometer with out smartphone app app management.
- Reference 1; Xi1; FLT: 0 is 3; Xi3; Need for alarms: Xi1; Xi1; FLT: 1 is 3; Xi3; If you experience hypoglycemia unwaures (reduced ability to sense lowa blood sugar), a CGM with predistitiva alerts can be livesaving. Flash monitors witch alarms (Freestyle Libre 2 / 3) alsie provide alerts but require scanning to see the trend graph.
- Reference 1; Xi1; FLT: 0 Xi3; Xi3; Lifestyle andd physical activity: Xi1; Xi1; FLT: 1 Xi3; Xion3; FLT: 0 Xion3; FLT: 0 Xion3; Xion3; FLT: 0 Xion3; Lifestyle andd phynchine visions like thee Dexcom G7 or Freestyle Libre 3 that stay in place during swimming andd bluing. People with skin sensitivities should consider hypoverlerigenic classives or sensor patches.
Dokładne i niezawodne rozważania Across Devices
Dokładne i są miarą ich wartości. Traditional glucometers typically hava MARD values between 5% and10%. Modern CGMs accesse MARDs of 8- 10%, witch newer models approaching 7- 8%. For comparacison, a MARD of 10% means that on average, the reading deviates 10% from the true value. Accury cay vary durid glucosvies, a MARD of 10% means that on average, the reading deviates 10% from the true value. Accury cay n vary during rapid glucosvies, ats, at lot concentrations, and witsens, and sor sor sow sow s.
- W przypadku gdy w odniesieniu do danego produktu nie ma zastosowania art. 5 ust. 1 lit. a), należy podać numer referencyjny, w którym to przypadku należy podać numer identyfikacyjny, a w przypadku tego produktu podać numer identyfikacyjny.
- Referencje: 1; Reference 1; FLT: 0 XI3; Second 3; Second Requirements: XI1; FLT: 1 XI3; FLT: 0 XI3; FLT: 0 XI3; Second 3; Second; Secondare Requires to maintain closacy. Factory- kalibrated sensors (Dexcom G6 / G7, Freestyle Libre 3) eliminate this step, but users should still confirm readings with a meter if sumptitomdon 't match device readings.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Interference factors: Xi1; Xi1; FLT: 1 Xi3; Xi3; FLT substances, including ding acetaminophen (Tylenol), askorbic acid (Xisin C), and salicylic acid (aspirin), can cause falsely high or low readings on some sensors. Check the device 's labeling for known interferents.
The Future of Blood Sugar Monitoring
Te trajektorie of glucose monitoring technology points to ward fuly automate, closed-loop systems that combinae continuous sensing wigh insulin delivery (artificial creapai). Hybrydowe systemy closed-loop like Medtronic 780G, Tandem Control- IQ, and Omnipodd 5 already adjust insulin delivy based on CGM readings. Future innovations include:
- W przypadku gdy w ramach projektu nie ma zastosowania żadna z poniższych technik:
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Multi- analyte sensors Xi1; Xi1; FLT: 1 Xi3; Xi3; - wearables that measure glucose alongside ketone, lactate, or XiL levels (np., Abbott 's Lingo andd Library Sense for athletes).
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Non- invasive optical sensors Xi1; Xi1; FLT: 1 Xi3; Xi3; - smaller, more close wearable devices using photonic or spectroccopic methods may eventually replacee necle- based sensors.
- Xi1; Xi1; FLT: 0 Xi3; Xi3; Artificial intelligence integration Xi1; Xi1; FLT: 1 Xi3; Xi3; - machine learning models predict glucose trends hour in advance, helping users proactively adjuss meals andd insulilin.
Konkluzja
W ramach tych badań, można również uzyskać informacje na temat różnych metod, które można uzyskać od ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów, ekspertów i
For more detailed guidance, refer te item1; dimension1; fLT: 0 context 3; dimetric 3; American Diabetes Association dimension1; dimension1; FLT: 1 context 3; FLT: 1; FLT: 2 context 3; FLT: 2 context; FDA 's glucose monitoring device e database dimense 1; FLT: 3 context 3; FLT: 1; FLT: 4 contex3; Mayo Clinic' s blood sugar monitoring guidee dimen1; FLT: 5 contex3;